Bayer in bid to broaden use of anti-clotting drug Xarelto - Reuters

Reuters

Bayer in bid to broaden use of anti-clotting drug Xarelto Reuters FRANKFURT (Reuters) - German drugmaker Bayer on Monday moved to tap a potentially lucrative new market opportunity for its blockbuster clot prevention drug Xarelto, requesting approval in Europe to make atherosclerosis patients eligible for treatment. Bayer Files for European Marketing Approval of New Xarelto IndicationFox Business all 2 news articles »

from Health - Google News http://ift.tt/2zkov2n